Transmyocardial laser revascularization (TMR) is emerging as a potential treatment option for path end-stage coronary artery disease who are not candidates for coronary
angioplasty or bypass surgery.
Log in or Become a member to view the full text of this article.
This article may be available for purchase via the search at www.osapublishing.org.
OSA Members get the full text of Optics & Photonics News, plus a variety of other member benefits.